Last reviewed · How we verify

NCT03321370

Cortical Spreading Depolarization After Severe Traumatic Brain Injury

Recruiting now Last updated 12 September 2025
What this trial tests

trial testing Continuous electrocorticography post severe traumatic brain injury requiring neurosurgical intervention in Traumatic Brain Injury in 10 participants. Currently enrolling.

Timeline
14 August 2019
Primary endpoint
1 November 2025
1 November 2025

Quick facts

Lead sponsorHennepin County Medical Center, Minneapolis
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment10
Start date14 August 2019
Primary completion1 November 2025
Estimated completion1 November 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Hennepin County Medical Center, Minneapolis

Who can join

18 and older, any sex, with Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Preliminary evaluation of electrodes placed on the brain for recording brain activity and novel algorithms to determine cortical spreading depolarization foci of origination following severe traumatic brain injury requiring neurosurgical intervention.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Mapping spreading depolarisations after traumatic brain injury: a pilot clinical study protocol.
    Cramer SW, Pino IP, Naik A, Carlson D, et al · · 2022 · cited 1× · PMID 35831043 · DOI 10.1136/bmjopen-2022-061663

Verify or expand the search:

Other recruiting trials for Traumatic Brain Injury

Currently open trials in the same condition.

Other Hennepin County Medical Center, Minneapolis trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03321370.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing